We use cookies, including third-party cookies from Google to serve personalized ads through AdSense, to operate this site and understand how it is used. By continuing to browse, you accept this use. See our Privacy Policy and Terms of Use for details, including how to opt out of personalized advertising.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Bio-Rad receives pre-market approval for HIV test from FDA
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Business > Bio-Rad receives pre-market approval for HIV test from FDA
BusinessDiagnostics

Bio-Rad receives pre-market approval for HIV test from FDA

HerinaAyot
HerinaAyot
Share
3 Min Read
SHARE

Bio-Rad Laboratories (NYSE:BIO) announced Monday it received FDA premarket approval for its fourth generation human immunodeficiency virus (HIV) diagnostic test.

Bio-Rad Laboratories (NYSE:BIO) announced Monday it received FDA premarket approval for its fourth generation human immunodeficiency virus (HIV) diagnostic test.

Because the testing kit was deemed a Class III medical device, it was required to undergo premarket approval – the FDA’s most stringent regulatory measure – to obtain marketing clearance, as not enough information exists about these types of devices to ensure safety and efficacy in other ways.

According to the FDA, a Class III device is one that supports or sustains human life, is of substantial importance in preventing impairment of human health, or which presents a potential and unreasonable risk of illness or injury.

More Read

EHR adoption Stage 2
Despite High EHR Adoption Rates, Physicians Want Stage 2 Delay
Tipping Point: Are Private Practice Doctors Becoming Extinct?
Google and ‘Rogue Pharmacy’ Ads Complaint
Physician-Led Advocacy Group Strives for Diversity among Its Profession
Health Wonk Review –April 14, 2011

Examples of Class III devices which currently require a premarket notification include implantable pacemaker, pulse generators, and HIV diagnostic tests, among other products.

Bio-Rad’s HIV diagnostic, GS HIV Combo Ag/Ab EIA (enzyme immunoassay), detects two types of HIV proteins: antigens, which are part of the HIV virus, and antibodies, which the body releases to fight the HIV infection.
The test’s ability to detect two types of HIV proteins allows for earlier detection of the virus.

Over one million Americans are living with HIV, and one in five of them are unaware of their infection. Untreated, a patient suffering from HIV will eventually develop acquired immunodeficiency syndrome (AIDS), and, without anti-retroviral treatment, a person infected with the AIDS virus typically dies within one year.

“Detecting HIV antigens and HIV antibodies in the same test provides clinicians with the ability to detect the virus at an earlier stage,” said Vice President and Group Manager, Clinical Diagnostics, John Goetz.

“This results in faster diagnosis of HIV-infected individuals so they are able to get the treatment they need more quickly.”

Clinical studies for the diagnostic test were performed at five major institutions in the U.S. The large sample population included adults and pediatric patients, in both low and high risk populations.

Based in Hercules, California, Bio-Rad said the GS HIV Combo Ag/Ab EIA can be used with its EVOLIS system, a self-contained automated microplate processor, or with manual testing systems.–Olivia D’Orazio

 

TAGGED:Bio-RaddiagnosticsFDAHIV diagnostic test
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5KFollowersLike
4.5KFollowersFollow
2.8KFollowersPin
136KSubscribersSubscribe

Latest News

Flat editorial illustration: Healthcare volunteer communication as a two-way, coordinator-supported process for confirming schedu
How to Manage Volunteer Communication in Healthcare: 5 Tactical Steps and Software Options
Global Healthcare
November 18, 2026
The Nervous System Reset Guide: Simple Ways To Manage Stress -- AI-generated illustration
The Nervous System Reset Guide: Simple Ways To Manage Stress
Infographics Mental Health
November 14, 2026
Flat editorial illustration: A single digital quality-management platform connects document control, electronic approval, audit r
6 Best QMS Software Platforms for ISO 13485 and FDA Part 820 (QMSR)
Global Healthcare Policy & Law
November 12, 2026
Flat editorial illustration: Healthcare editorial illustration about accurate patient intake connecting registration, clinical re
The Role of Patient Data Accuracy in Healthcare Operations
Global Healthcare Policy & Law
November 11, 2026

You Might also Like

Bill McGuire on Wireless Health and Technology

April 7, 2011
uninsured
BusinessFinance

Who’s Paying the Chargemaster Rate? Not Just the Uninsured

October 10, 2014
big data in healthcare
BusinesseHealthHealth ReformMedical RecordsPolicy & Law

Big Data = Big Savings in Healthcare

March 7, 2014
icd 10 delay
BusinessFinanceHealth ReformHospital AdministrationMedical RecordsNewsPolicy & Law

ICD-10 Delay: Does ICD-10 Lack Clinical Value?

April 13, 2014
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2026 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?